Literature DB >> 26656880

Brain Biomarkers of Vulnerability and Progression to Psychosis.

Tyrone D Cannon1.   

Abstract

Identifying predictors and elucidating the fundamental mechanisms underlying onset of psychosis are critical for the development of targeted preemptive interventions. This article presents a selective review of findings on risk prediction algorithms and potential mechanisms of onset in youth at clinical high-risk for psychosis, focusing principally on recent findings of the North American Prodrome Longitudinal Study (NAPLS). Multivariate models incorporating risk factors from clinical, demographic, neurocognitive, and psychosocial assessments achieve high levels of predictive accuracy when applied to individuals who meet criteria for a prodromal risk syndrome. An individualized risk calculator is available to scale the risk for newly ascertained cases, which could aid in clinical decision making. At risk individuals who convert to psychosis show elevated levels of proinflammatory cytokines, as well as disrupted resting state thalamo-cortical functional connectivity at baseline, compared with those who do not. Further, converters show a steeper rate of gray matter reduction, most prominent in prefrontal cortex, that in turn is predicted by higher levels of inflammatory markers at baseline. Microglia, resident immune cells in the brain, have recently been discovered to influence synaptic plasticity in health and impair plasticity in disease. Processes that modulate microglial activation may represent convergent mechanisms that influence brain dysconnectivity and risk for onset of psychosis and thus may be targetable in developing and testing preventive interventions.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  prevention; prodrome; psychosis

Mesh:

Substances:

Year:  2015        PMID: 26656880      PMCID: PMC4960430          DOI: 10.1093/schbul/sbv173

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  79 in total

1.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Authors:  Dejan Milatovic; Ramesh C Gupta; Yingchun Yu; Snjezana Zaja-Milatovic; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

2.  Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Authors:  Danielle A Schlosser; Sarah Jacobson; Qiaolin Chen; Catherine A Sugar; Tara A Niendam; Gang Li; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2011-08-08       Impact factor: 9.306

Review 3.  The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS.

Authors:  Dorothy P Schafer; Emily K Lehrman; Beth Stevens
Journal:  Glia       Date:  2012-07-24       Impact factor: 7.452

Review 4.  Developmental neuroinflammation and schizophrenia.

Authors:  Urs Meyer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-11-15       Impact factor: 5.067

Review 5.  A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.

Authors:  John E Lisman; Hyun Jae Pi; Yuchun Zhang; Nonna A Otmakhova
Journal:  Biol Psychiatry       Date:  2010-05-31       Impact factor: 13.382

6.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 7.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

8.  Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.

Authors:  Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-01-12       Impact factor: 4.939

Review 9.  Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Authors:  S Navari; P Dazzan
Journal:  Psychol Med       Date:  2009-04-02       Impact factor: 7.723

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  8 in total

1.  Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.

Authors:  Jun Konishi; Elisabetta C Del Re; Sylvain Bouix; Gabriëlla A M Blokland; Raquelle Mesholam-Gately; Kristen Woodberry; Margaret Niznikiewicz; Jill Goldstein; Yoshio Hirayasu; Tracey L Petryshen; Larry J Seidman; Martha E Shenton; Robert W McCarley
Journal:  Brain Imaging Behav       Date:  2018-08       Impact factor: 3.978

2.  Cortical Gyrification, Psychotic-Like Experiences, and Cognitive Performance in Nonclinical Subjects.

Authors:  Ulrika Evermann; Christian Gaser; Bianca Besteher; Kerstin Langbein; Igor Nenadić
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

Review 3.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Authors:  Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2016-04-09       Impact factor: 8.989

4.  Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort.

Authors:  Jane A English; Lorna M Lopez; Aoife O'Gorman; Melanie Föcking; Magdalena Hryniewiecka; Caitriona Scaife; Sophie Sabherwal; Kieran Wynne; Patrick Dicker; Bart P F Rutten; Glynn Lewis; Stanley Zammit; Mary Cannon; Gerard Cagney; David R Cotter
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

5.  Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis.

Authors:  Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert
Journal:  World J Biol Psychiatry       Date:  2020-07-09       Impact factor: 4.132

6.  Cognitive subtypes in recent onset psychosis: distinct neurobiological fingerprints?

Authors:  Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Julian Wenzel; Shalaila S Haas; Dominic B Dwyer; Anne Ruef; Oemer Faruk Oeztuerk; Linda A Antonucci; Sebastian von Saldern; Carolina Bonivento; Marco Garzitto; Adele Ferro; Marco Paolini; Janusch Blautzik; Stefan Borgwardt; Paolo Brambilla; Eva Meisenzahl; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2021-03-15       Impact factor: 7.853

7.  Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Miriam Ayora; Fabián Hernández-Álvarez; Alberto Rodríguez-Quiroga; Sandra Recio; Juan C Leza; Celso Arango
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 7.348

8.  Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia.

Authors:  Kristin K Lottman; Nina V Kraguljac; David M White; Charity J Morgan; Vince D Calhoun; Allison Butt; Adrienne C Lahti
Journal:  Front Psychiatry       Date:  2017-02-06       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.